Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1038/leu.2009.128 | DOI Listing |
Curr Pediatr Rev
September 2024
Neonatology Unit, Department of Medicine and Surgery, University of Parma, Via Gramsci 14, 43126, Parma, Italy.
We read a review of case reports published on Current Pediatric Reviews 2024 about the use of I-gel® in neonatal complicated intubation, and we decided to write a commentary on the benefits and limitations of using supraglottic airways in neonatal age, with a specific focus on Igel [1]. The use of supraglottic airway devices in neonatal ages is limited to particular conditions, but further research is showing the utility of these devices as the first choice in neonatal resuscitation or airway stabilization. Our commentary highlights the broader practical applications of I-gel and reinforces its role as a valuable tool in neonatal resuscitation.
View Article and Find Full Text PDFFront Immunol
February 2024
Department of Pulmonary Oncology, AORN Azienda Ospedaliera dei Colli Monaldi, Naples, Italy.
Background: Consolidative thoracic radiotherapy (TRT) has been commonly used in the management of extensive-stage small cell lung cancer (ES-SCLC). Nevertheless, phase III trials exploring first-line chemoimmunotherapy have excluded this treatment approach. However, there is a strong biological rationale to support the use of radiotherapy (RT) as a boost to sustain anti-tumor immune responses.
View Article and Find Full Text PDFInt J Gynecol Cancer
January 2024
Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
JAMA
December 2023
Department of Emergency Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
JAMA Netw Open
September 2023
Department of Emergency Medicine, Medical Toxicology and Addiction Medicine Initiatives, Center for Addiction Medicine and Policy, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!